Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
| 9.15 Delayed Data As of Jun 22 |  -0.32 / -3.38%Today’s Change | 7.37 Today|||52-Week Range 15.40 | -10.73% Year-to-Date |
Latest MACK News | Press Releases
| Options Traders Expect Huge Moves in Merrimack Pharmaceuticals (MACK) Stock Jun 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.47 |
| Today’s open | 9.47 |
| Day’s range | 9.08 - 9.53 |
| Volume | 1,700,661 |
| Average volume (3 months) | 160,562 |
| Market cap | -- |
Data as of 4:15pm ET, 06/22/2018
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRHMCRH Medical Corp | +0.05 | +1.47% |
| OCULOcular Therapeutix I... | +0.04 | +0.58% |
| CLSDClearside Biomedical... | +0.04 | +0.39% |
| OCXOncoCyte Corp | +0.85 | +36.96% |
Data as of 8:00pm ET, 06/22/2018
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector -- |
Industry -- |
No executives to display |
Corporate headquarters --, -- |
Forecasts
